Venetoclax

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a recent article by Yuchen Liu on X:

“Very interesting study in Blood Journal looking at Pegcrisantaspase + Ven in R/R AML (68% of patients with prior Ven exposure)!”

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax in relapsed or refractory acute myeloid leukemia.

Authors: Yuchen Liu, et al.

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

 

Acute Myeloid Leukemia AML Anand Patel Blood Journal cancer OncoDaily Oncology Pegcrisantaspase venetoclax Yuchen Liu